Tokyo, April 10 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000061212) titled 'Validation of the Reliability and Validity of the Oxford Cognitive Screening-Plus for Patients with Brain Injury' on April 10.
Study Type:
Observational
Primary Sponsor:
Institute - Tokyo Metropolitan University
Condition:
Condition - Patients with Brain injury
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - The purpose of this study is to clarify the reliability and validity of the OCS-Plus in patients with brain injury.
Basic objectives2 - Efficacy
Eligibility:
Age-lower limit - 18
years-old
=
Gender - Male and Female
Key inclusion criteria - Patients with a f...